NERATINIB for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where NERATINIB was used for Off label use.
Most Reported Side Effects for NERATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 1,193 | 57.1% | 150 | 358 |
| Nausea | 527 | 25.2% | 56 | 150 |
| Fatigue | 446 | 21.4% | 71 | 118 |
| Off label use | 383 | 18.3% | 137 | 178 |
| Vomiting | 297 | 14.2% | 44 | 128 |
| Constipation | 267 | 12.8% | 23 | 67 |
| Decreased appetite | 245 | 11.7% | 62 | 93 |
| Death | 181 | 8.7% | 181 | 48 |
| Disease progression | 142 | 6.8% | 92 | 78 |
| Weight decreased | 132 | 6.3% | 55 | 55 |
| Dehydration | 129 | 6.2% | 12 | 75 |
| Abdominal pain | 114 | 5.5% | 19 | 29 |
| Headache | 110 | 5.3% | 6 | 38 |
| Dizziness | 96 | 4.6% | 6 | 32 |
| Abdominal pain upper | 95 | 4.6% | 6 | 26 |
Other Indications for NERATINIB
Breast cancer (714)
Breast cancer female (417)
Product used for unknown indication (280)
Her2 positive breast cancer (274)
Breast cancer metastatic (207)
Her-2 positive breast cancer (88)
Neoplasm malignant (20)
Metastatic neoplasm (19)
Metastases to central nervous system (15)
Breast cancer stage iv (12)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)